Clinical trials
Phase 2 Obesity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
369 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 5 |
| 2004 | 8 |
| 2005 | 14 |
| 2006 | 16 |
| 2007 | 13 |
| 2008 | 19 |
| 2009 | 14 |
| 2010 | 10 |
| 2011 | 11 |
| 2012 | 10 |
| 2013 | 12 |
| 2014 | 9 |
| 2015 | 11 |
| 2016 | 7 |
| 2017 | 18 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 17 |
| 2022 | 12 |
| 2023 | 17 |
| 2024 | 35 |
| 2025 | 41 |
| 2026 | 39 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 234 |
| Recruiting | 41 |
| Active, not recruiting | 30 |
| Terminated | 29 |
| Withdrawn | 13 |
| Not yet recruiting | 12 |
| Unknown status | 6 |
| Enrolling by invitation | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 20 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 19 |
| AstraZeneca | 14 |
| Pfizer | 10 |
| Novo Nordisk A/S | 9 |
| Novartis Pharmaceuticals | 7 |
| Washington University School of Medicine | 7 |
| Massachusetts General Hospital | 6 |
| Mayo Clinic | 6 |
| Orexigen Therapeutics, Inc | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 369 |
| Overweight | 133 |
| Weight Loss | 55 |
| Diabetes Mellitus, Type 2 | 39 |
| Diabetes Mellitus | 30 |
| Insulin Resistance | 24 |
| Hypertension | 14 |
| Non-alcoholic Fatty Liver Disease | 13 |
| Asthma | 12 |
| Metabolic Syndrome | 11 |
Trials
Showing 1 to 25 of 369. Each trial links to its page on Pharma Observatory.
269 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.